Patents by Inventor Myoung Ki JEONG

Myoung Ki JEONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical combination formulation comprising amlodipine, losartan and rosuvastatin
    Patent number: 9833413
    Abstract: Disclosed is a pharmaceutical combination formulation comprising a first discrete part containing amlodipine and rosuvastatin and a second discrete part containing losartan, which exhibits improved dissolution rate and stability. The inventive combination formulation comprising amlodipine, losartan and rosuvastatin having different action mechanisms from one another can be effectively used to prevent or treat a cardiovascular disorder. Designed to minimize an interaction among active ingredients, the pharmaceutical combination formulation exhibits excellent storage stability and dissolution rates of amlodipine, losartan and rosuvastatin, and thus can be useful in pharmaceutical industries.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: December 5, 2017
    Assignee: HANMI PHARM. CO., LTD
    Inventors: Ho Taek Im, Myoung Ki Jeong, Yong Il Kim, Jae Hyun Park, Jong Soo Woo, Hyuk Jun Cho
  • PHARMACEUTICAL COMBINATION FORMULATION COMPRISING AMLODIPINE, LOSARTAN AND ROSUVASTATIN
    Publication number: 20170027871
    Abstract: Disclosed is a pharmaceutical combination formulation comprising a first discrete part containing amlodipine and rosuvastatin and a second discrete part containing losartan, which exhibits improved dissolution rate and stability. The inventive combination formulation comprising amlodipine, losartan and rosuvastatin having different action mechanisms from one another can be effectively used to prevent or treat a cardiovascular disorder. Designed to minimize an interaction among active ingredients, the pharmaceutical combination formulation exhibits excellent storage stability and dissolution rates of amlodipine, losartan and rosuvastatin, and thus can be useful in pharmaceutical industries.
    Type: Application
    Filed: November 20, 2014
    Publication date: February 2, 2017
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Ho Taek IM, Myoung Ki JEONG, Yong Il KIM, Jae Hyun PARK, Jong Soo WOO, Hyuk Jun CHO